{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T11:04:51Z","timestamp":1780398291743,"version":"3.54.1"},"reference-count":166,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T00:00:00Z","timestamp":1705363200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>The gut-liver axis refers to the intimate relationship and rigorous interaction between the gut and the liver. The intestinal barrier\u2019s integrity is critical for maintaining liver homeostasis. The liver operates as a second firewall in this interaction, limiting the movement of potentially dangerous compounds from the gut and, as a result, contributing in barrier management. An increasing amount of evidence shows that increased intestinal permeability and subsequent bacterial translocation play a role in liver damage development. The major pathogenic causes in cirrhotic individuals include poor intestinal permeability, nutrition, and intestinal flora dysbiosis. Portal hypertension promotes intestinal permeability and bacterial translocation in advanced liver disease, increasing liver damage. Bacterial dysbiosis is closely related to the development of cirrhosis and its related complications. This article describes the potential mechanisms of dysbiosis in liver cirrhosis and related complications, such as spontaneous bacterial peritonitis, hepatorenal syndrome, portal vein thrombosis, hepatic encephalopathy, and hepatocellular carcinoma, using dysbiosis of the intestinal flora as an entry point.<\/jats:p>","DOI":"10.3389\/fmed.2023.1320015","type":"journal-article","created":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T04:15:55Z","timestamp":1705378555000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["Liver cirrhosis and complications from the perspective of dysbiosis"],"prefix":"10.3389","volume":"10","author":[{"given":"Guole","family":"Nie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honglong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danna","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,1,16]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.1478-3231.2011.02517.x","article-title":"All-cause mortality in people with cirrhosis compared with the general population: a population-based cohort study","volume":"32","author":"Fleming","year":"2012","journal-title":"Liver Int"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/S0140-6736(21)01374-X","article-title":"Liver cirrhosis","volume":"398","author":"Gin\u00e8s","year":"2021","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.jhep.2018.05.011","article-title":"Burden of liver disease in Europe: epidemiology and analysis of risk factors to identify prevention policies","volume":"69","author":"Pimpin","year":"2018","journal-title":"J Hepatol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.jhep.2019.03.004","article-title":"Global liver disease burdens and research trends: analysis from a Chinese perspective","volume":"71","author":"Xiao","year":"2019","journal-title":"J Hepatol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.mam.2018.09.002","article-title":"Liver fibrosis: pathophysiology, pathogenetic targets and clinical issues","volume":"65","author":"Parola","year":"2019","journal-title":"Mol Aspects Med"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.jhep.2019.10.003","article-title":"The gut-liver axis in liver disease: pathophysiological basis for therapy","volume":"72","author":"Albillos","year":"2020","journal-title":"J Hepatol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"e1002533","DOI":"10.1371\/journal.pbio.1002533","article-title":"Revised estimates for the number of human and bacteria cells in the body","volume":"14","author":"Sender","year":"2016","journal-title":"PLoS Biol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.advms.2017.04.005","article-title":"The human microbiome","volume":"62","author":"Blum","year":"2017","journal-title":"Adv Med Sci"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1038\/s41564-021-00904-0","article-title":"Fetal meconium does not have a detectable microbiota before birth","volume":"6","author":"Kennedy","year":"2021","journal-title":"Nat Microbiol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s11154-019-09512-0","article-title":"Dietary lipids, gut microbiota and lipid metabolism","volume":"20","author":"Schoeler","year":"2019","journal-title":"Rev Endocr Metab Disord"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1093\/advances\/nmab047","article-title":"A systematic review of dietary influences on fecal microbiota composition and function among healthy humans 1\u201320 years of age","volume":"12","author":"Dinsmoor","year":"2021","journal-title":"Adv Nutr"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s40168-021-01046-5","article-title":"Androgen-induced gut dysbiosis disrupts glucolipid metabolism and endocrinal functions in polycystic ovary syndrome","volume":"9","author":"Han","year":"2021","journal-title":"Microbiome"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"6277","DOI":"10.1038\/s41380-021-01113-1","article-title":"Gut microbiota modulates the inflammatory response and cognitive impairment induced by sleep deprivation","volume":"26","author":"Wang","year":"2021","journal-title":"Mol Psychiatry"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/nbt.2942","article-title":"An integrated catalog of reference genes in the human gut microbiome","volume":"32","author":"Li","year":"2014","journal-title":"Nat Biotechnol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.trsl.2019.02.005","article-title":"Role of the intestinal microbiome in liver fibrosis development and new treatment strategies","volume":"209","author":"Zhou","year":"2019","journal-title":"Transl Res"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1096\/fj.14-259515","article-title":"Commensal microbiota is hepatoprotective and prevents liver fibrosis in mice","volume":"29","author":"Mazagova","year":"2015","journal-title":"FASEB J"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.tem.2018.01.002","article-title":"Bilirubin in the liver-gut signaling axis","volume":"29","author":"Hamoud","year":"2018","journal-title":"Trends Endocrinol Metab"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"3920","DOI":"10.1073\/pnas.0509592103","article-title":"Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor","volume":"103","author":"Inagaki","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.mam.2017.06.002","article-title":"Interactions between gut bacteria and bile in health and disease","volume":"56","author":"Long","year":"2017","journal-title":"Mol Aspects Med"},{"key":"ref20","first-page":"91","article-title":"Evaluation of bacterial translocation in patients with chronic HCV infection","volume":"52","author":"Munteanu","year":"2014","journal-title":"Rom J Intern Med"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"e94416","DOI":"10.1172\/jci.insight.94416","article-title":"Microbiota, cirrhosis, and the emerging oral-gut-liver axis","volume":"2","author":"Acharya","year":"2017","journal-title":"JCI Insight"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.cmet.2016.05.005","article-title":"Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism","volume":"24","author":"Wahlstr\u00f6m","year":"2016","journal-title":"Cell Metab"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.5604\/01.3001.0010.5493","article-title":"Bile acid physiology","volume":"16","author":"Di Ciaula","year":"2017","journal-title":"Ann Hepatol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"102045","DOI":"10.1016\/j.cis.2019.102045","article-title":"Bile salts in digestion and transport of lipids","volume":"274","author":"Macierzanka","year":"2019","journal-title":"Adv Colloid Interf Sci"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"2364","DOI":"10.1111\/j.1572-0241.2002.05791.x","article-title":"Small intestinal bacterial overgrowth in human cirrhosis is associated with systemic endotoxemia","volume":"97","author":"Bauer","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"4523","DOI":"10.1073\/pnas.1006734107","article-title":"Systemic gut microbial modulation of bile acid metabolism in host tissue compartments","volume":"108","author":"Swann","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1124\/pr.113.008201","article-title":"Bile acid signaling in metabolic disease and drug therapy","volume":"66","author":"Li","year":"2014","journal-title":"Pharmacol Rev"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.ajpath.2014.10.009","article-title":"The FXR agonist obeticholic acid prevents gut barrier dysfunction and bacterial translocation in cholestatic rats","volume":"185","author":"Verbeke","year":"2015","journal-title":"Am J Pathol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/j.jhep.2015.12.010","article-title":"Obeticholic acid reduces bacterial translocation and inhibits intestinal inflammation in cirrhotic rats","volume":"64","author":"\u00dabeda","year":"2016","journal-title":"J Hepatol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"11597","DOI":"10.3748\/wjg.v21.i41.11597","article-title":"Gut microbiota and host metabolism in liver cirrhosis","volume":"21","author":"Usami","year":"2015","journal-title":"World J Gastroenterol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"395","DOI":"10.3390\/ijms20020395","article-title":"Gut-liver axis, gut microbiota, and its modulation in the management of liver diseases: a review of the literature","volume":"20","author":"Milosevic","year":"2019","journal-title":"Int J Mol Sci"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"997018","DOI":"10.3389\/fcimb.2022.997018","article-title":"Gut dysbiosis in nonalcoholic fatty liver disease: pathogenesis, diagnosis, and therapeutic implications","volume":"12","author":"Fang","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/j.jhep.2013.12.019","article-title":"Altered profile of human gut microbiome is associated with cirrhosis and its complications","volume":"60","author":"Bajaj","year":"2014","journal-title":"J Hepatol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.3389\/fimmu.2020.01994","article-title":"Dysbiosis of gut microbiota and short-chain fatty acids in encephalitis: a Chinese pilot study","volume":"11","author":"Xu","year":"2020","journal-title":"Front Immunol"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3390\/biom12010056","article-title":"Understanding the role of the gut microbiome and microbial metabolites in non-alcoholic fatty liver disease: current evidence and perspectives","volume":"12","author":"Vallianou","year":"2021","journal-title":"Biomol Ther"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"15080","DOI":"10.1038\/nrdp.2015.80","article-title":"Nonalcoholic fatty liver disease","volume":"1","author":"Brunt","year":"2015","journal-title":"Nat Rev Dis Primers"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.jhep.2008.10.028","article-title":"Evidence that chronic alcohol exposure promotes intestinal oxidative stress, intestinal hyperpermeability and endotoxemia prior to development of alcoholic steatohepatitis in rats","volume":"50","author":"Keshavarzian","year":"2009","journal-title":"J Hepatol"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"G1356","DOI":"10.1152\/ajpgi.00526.2011","article-title":"Acetaldehyde disrupts tight junctions in Caco-2 cell monolayers by a protein phosphatase 2A-dependent mechanism","volume":"303","author":"Dunagan","year":"2012","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1002\/hep.28356","article-title":"The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota","volume":"63","author":"Boursier","year":"2016","journal-title":"Hepatology"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1007\/s00018-019-03011-w","article-title":"The links between the gut microbiome and non-alcoholic fatty liver disease (NAFLD)","volume":"76","author":"Safari","year":"2019","journal-title":"Cell Mol Life Sci"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/j.jhep.2012.11.023","article-title":"The gut microbiota and the liver. Pathophysiological and clinical implications","volume":"58","author":"Quigley","year":"2013","journal-title":"J Hepatol"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.4254\/wjh.v7.i17.2058","article-title":"Intestinal barrier dysfunction in cirrhosis: current concepts in pathophysiology and clinical implications","volume":"7","author":"Tsiaoussis","year":"2015","journal-title":"World J Hepatol"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/j.jhep.2017.07.002","article-title":"Gut-derived endotoxin stimulates factor VIII secretion from endothelial cells. Implications for hypercoagulability in cirrhosis","volume":"67","author":"Carnevale","year":"2017","journal-title":"J Hepatol"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"8096","DOI":"10.1038\/srep08096","article-title":"Dysbiosis gut microbiota associated with inflammation and impaired mucosal immune function in intestine of humans with non-alcoholic fatty liver disease","volume":"5","author":"Jiang","year":"2015","journal-title":"Sci Rep"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1002\/hep.24423","article-title":"Characterization of fecal microbial communities in patients with liver cirrhosis","volume":"54","author":"Chen","year":"2011","journal-title":"Hepatology"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"G966","DOI":"10.1152\/ajpgi.00380.2011","article-title":"Colonic microbiome is altered in alcoholism","volume":"302","author":"Mutlu","year":"2012","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"G929","DOI":"10.1152\/ajpgi.00315.2013","article-title":"Colonic inflammation and secondary bile acids in alcoholic cirrhosis","volume":"306","author":"Kakiyama","year":"2014","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1111\/acer.13498","article-title":"Continued alcohol misuse in human cirrhosis is associated with an impaired gut-liver axis","volume":"41","author":"Bajaj","year":"2017","journal-title":"Alcohol Clin Exp Res"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s40168-017-0359-2","article-title":"Links of gut microbiota composition with alcohol dependence syndrome and alcoholic liver disease","volume":"5","author":"Dubinkina","year":"2017","journal-title":"Microbiome"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1002\/hep.26319","article-title":"Intestinal microbiota in patients with nonalcoholic fatty liver disease","volume":"58","author":"Mouzaki","year":"2013","journal-title":"Hepatology"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/j.cgh.2013.02.015","article-title":"Fecal microbiome and volatile organic compound metabolome in obese humans with nonalcoholic fatty liver disease","volume":"11","author":"Raman","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1002\/hep.26093","article-title":"Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH","volume":"57","author":"Zhu","year":"2013","journal-title":"Hepatology"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1016\/S0140-6736(14)60121-5","article-title":"Liver cirrhosis","volume":"383","author":"Tsochatzis","year":"2014","journal-title":"Lancet"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1080\/17474124.2017.1343663","article-title":"Gut microbiota changes and chronic hepatitis C virus infection","volume":"11","author":"Preveden","year":"2017","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/9726786","article-title":"Advances in gut microbiota of viral hepatitis cirrhosis","volume":"2019","author":"Wang","year":"2019","journal-title":"Biomed Res Int"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"34055","DOI":"10.1038\/srep34055","article-title":"Dysbiosis of small intestinal microbiota in liver cirrhosis and its association with etiology","volume":"6","author":"Chen","year":"2016","journal-title":"Sci Rep"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1021\/acsinfecdis.0c00432","article-title":"Alterations of the treatment-naive gut microbiome in newly diagnosed hepatitis C virus infection","volume":"7","author":"Sultan","year":"2021","journal-title":"ACS Infect Dis"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1111\/apt.13732","article-title":"HCV eradication does not impact gut dysbiosis or systemic inflammation in cirrhotic patients","volume":"44","author":"Bajaj","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1111\/apt.15004","article-title":"Influence of hepatitis C virus eradication with direct-acting antivirals on the gut microbiota in patients with cirrhosis","volume":"48","author":"Ponziani","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1007\/s00248-011-9925-5","article-title":"Changes of fecal Bifidobacterium species in adult patients with hepatitis B virus-induced chronic liver disease","volume":"63","author":"Xu","year":"2012","journal-title":"Microb Ecol"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/1471-230X-13-175","article-title":"Abnormal fecal microbiota community and functions in patients with hepatitis B liver cirrhosis as revealed by a metagenomic approach","volume":"13","author":"Wei","year":"2013","journal-title":"BMC Gastroenterol"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nature13568","article-title":"Alterations of the human gut microbiome in liver cirrhosis","volume":"513","author":"Qin","year":"2014","journal-title":"Nature"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13099-016-0124-2","article-title":"Gut microbiome alterations in patients with stage 4 hepatitis C","volume":"8","author":"Aly","year":"2016","journal-title":"Gut Pathog"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1093\/cid\/ciy205","article-title":"Gut dysbiosis associated with hepatitis C virus infection","volume":"67","author":"Inoue","year":"2018","journal-title":"Clin Infect Dis"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/liv.13485","article-title":"Intestinal microbiota in patients with chronic hepatitis C with and without cirrhosis compared with healthy controls","volume":"38","author":"Heidrich","year":"2018","journal-title":"Liver Int"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/jvh.13216","article-title":"Gut microbiota dysbiosis in patients with hepatitis B virus-induced chronic liver disease covering chronic hepatitis, liver cirrhosis and hepatocellular carcinoma","volume":"27","author":"Zeng","year":"2020","journal-title":"J Viral Hepat"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1111\/1751-2980.12970","article-title":"Consensus for management of portal vein thrombosis in liver cirrhosis","volume":"22","year":"2020","journal-title":"J Dig Dis"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1097\/MCG.0000000000000834","article-title":"Portal vein thrombosis in cirrhosis","volume":"51","author":"Loudin","year":"2017","journal-title":"J Clin Gastroenterol"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/liv.13500","article-title":"Decreased portal vein velocity is predictive of the development of portal vein thrombosis: a matched case-control study","volume":"38","author":"Stine","year":"2018","journal-title":"Liver Int"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.thromres.2020.03.003","article-title":"The gut microbiome and thromboembolism","volume":"189","author":"Hasan","year":"2020","journal-title":"Thromb Res"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1172\/JCI112772","article-title":"Endotoxin enhances tissue factor and suppresses thrombomodulin expression of human vascular endothelium in vitro","volume":"79","author":"Moore","year":"1987","journal-title":"J Clin Invest"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1146\/annurev-biochem-060713-035600","article-title":"Biosynthesis and export of bacterial lipopolysaccharides","volume":"83","author":"Whitfield","year":"2014","journal-title":"Annu Rev Biochem"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.critrevonc.2016.01.007","article-title":"Inflammation as a cause of venous thromboembolism","volume":"99","author":"Saghazadeh","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3389\/fped.2018.00142","article-title":"The role of inflammation in venous thromboembolism","volume":"6","author":"Branchford","year":"2018","journal-title":"Front Pediatr"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1007\/s00277-020-04075-6","article-title":"LPS-induced expression and release of monocyte tissue factor in patients with haemophilia","volume":"99","author":"Holstein","year":"2020","journal-title":"Ann Hematol"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1097\/MEG.0b013e32834a75dc","article-title":"Endotoxin and tumor necrosis factor-receptor levels in portal and hepatic vein of patients with alcoholic liver cirrhosis receiving elective transjugular intrahepatic portosystemic shunt","volume":"23","author":"Trebicka","year":"2011","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"237ra66","DOI":"10.1126\/scitranslmed.3008618","article-title":"The liver may act as a firewall mediating mutualism between the host and its gut commensal microbiota","volume":"6","author":"Balmer","year":"2014","journal-title":"Sci Transl Med"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1113\/jphysiol.2011.219691","article-title":"Role of innate immunity and the microbiota in liver fibrosis: crosstalk between the liver and gut","volume":"590","author":"Seki","year":"2012","journal-title":"J Physiol"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3389\/fimmu.2014.00221","article-title":"Role of toll-like receptors in immune activation and tolerance in the liver","volume":"5","author":"Nakamoto","year":"2014","journal-title":"Front Immunol"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"233","DOI":"10.24875\/CIRU.19000725","article-title":"Platelet activation as a trigger factor for inflammation and atherosclerosis","volume":"88","author":"Custodio-Chabl\u00e9","year":"2020","journal-title":"Cir Cir"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","article-title":"Mechanisms of hepatic stellate cell activation","volume":"14","author":"Tsuchida","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1055\/s-0038-1675357","article-title":"The gut microbiota as an influencing factor of arterial thrombosis","volume":"39","author":"Reinhardt","year":"2019","journal-title":"Hamostaseologie"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1182\/blood-2016-11-754416","article-title":"Gut microbiota regulate hepatic von Willebrand factor synthesis and arterial thrombus formation via toll-like receptor-2","volume":"130","author":"J\u00e4ckel","year":"2017","journal-title":"Blood"},{"key":"ref84","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.4049\/jimmunol.1001647","article-title":"Bacterial lipoprotein TLR2 agonists broadly modulate endothelial function and coagulation pathways in vitro and in vivo","volume":"186","author":"Shin","year":"2011","journal-title":"J Immunol"},{"key":"ref85","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1111\/j.1440-1711.2005.01314.x","article-title":"Evidence of toll-like receptor molecules on human platelets","volume":"83","author":"Cognasse","year":"2005","journal-title":"Immunol Cell Biol"},{"key":"ref86","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1161\/CIRCRESAHA.108.185785","article-title":"Stimulation of toll-like receptor 2 in human platelets induces a thromboinflammatory response through activation of phosphoinositide 3-kinase","volume":"104","author":"Blair","year":"2009","journal-title":"Circ Res"},{"key":"ref87","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1160\/TH08-08-0513","article-title":"Immune versus thrombotic stimulation of platelets differentially regulates signalling pathways, intracellular protein\u2013protein interactions, and alpha-granule release","volume":"102","author":"Rex","year":"2009","journal-title":"Thromb Haemost"},{"key":"ref88","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3390\/nu13010144","article-title":"Role of gut microbiota and their metabolites on atherosclerosis, hypertension and human blood platelet function: a review","volume":"13","author":"Duttaroy","year":"2021","journal-title":"Nutrients"},{"key":"ref89","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/nri3345","article-title":"Thrombosis as an intravascular effector of innate immunity","volume":"13","author":"Engelmann","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"ref90","doi-asserted-by":"publisher","first-page":"236","DOI":"10.3389\/fimmu.2016.00236","article-title":"The emerging role of NETs in venous thrombosis and immunothrombosis","volume":"7","author":"Kimball","year":"2016","journal-title":"Front Immunol"},{"key":"ref91","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/j.1538-7836.2011.04544.x","article-title":"Neutrophil extracellular traps promote deep vein thrombosis in mice","volume":"10","author":"Brill","year":"2012","journal-title":"J Thromb Haemost"},{"key":"ref92","doi-asserted-by":"publisher","first-page":"107602961882531","DOI":"10.1177\/1076029618825310","article-title":"Contact system activation and neutrophil extracellular trap markers: risk factors for portal vein thrombosis in patients with hepatocellular carcinoma","volume":"25","author":"Seo","year":"2019","journal-title":"Clin Appl Thromb Hemost"},{"key":"ref93","doi-asserted-by":"publisher","first-page":"4020","DOI":"10.1038\/s41598-018-22156-5","article-title":"Neutrophil extracellular trap-microparticle complexes enhance thrombin generation via the intrinsic pathway of coagulation in mice","volume":"8","author":"Wang","year":"2018","journal-title":"Sci Rep"},{"key":"ref94","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1182\/blood-2011-03-343061","article-title":"Extracellular histones promote thrombin generation through platelet-dependent mechanisms: involvement of platelet TLR2 and TLR4","volume":"118","author":"Semeraro","year":"2011","journal-title":"Blood"},{"key":"ref95","doi-asserted-by":"publisher","first-page":"e00199","DOI":"10.1128\/mSphere.00199-16","article-title":"Extreme Dysbiosis of the microbiome in critical illness","volume":"1","author":"McDonald","year":"2016","journal-title":"mSphere"},{"key":"ref96","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1111\/apm.13038","article-title":"Gut microbiota in atherosclerosis: focus on trimethylamine N-oxide","volume":"128","author":"Zhu","year":"2020","journal-title":"APMIS"},{"key":"ref97","doi-asserted-by":"publisher","first-page":"2494","DOI":"10.1056\/NEJMcibr1604458","article-title":"A gut feeling about thrombosis","volume":"374","author":"Tilg","year":"2016","journal-title":"N Engl J Med"},{"key":"ref98","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.cell.2016.02.011","article-title":"Gut microbial metabolite TMAO enhances platelet hyperreactivity and thrombosis risk","volume":"165","author":"Zhu","year":"2016","journal-title":"Cells"},{"key":"ref99","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1053\/j.gastro.2009.08.045","article-title":"An imbalance of pro- vs. anti-coagulation factors in plasma from patients with cirrhosis","volume":"137","author":"Tripodi","year":"2009","journal-title":"Gastroenterology"},{"key":"ref100","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1002\/hep4.1317","article-title":"Serum albumin is inversely associated with portal vein thrombosis in cirrhosis","volume":"3","author":"Basili","year":"2019","journal-title":"Hepatol Commun"},{"key":"ref101","doi-asserted-by":"publisher","first-page":"e13508","DOI":"10.1111\/ijcp.13508","article-title":"Hypertriglyceridemia is associated with platelet hyperactivation in metabolic syndrome patients","volume":"74","author":"Wang","year":"2020","journal-title":"Int J Clin Pract"},{"key":"ref102","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.thromres.2020.12.002","article-title":"Translational insight into prothrombotic state and hypercoagulation in nonalcoholic fatty liver disease","volume":"198","author":"Ciavarella","year":"2021","journal-title":"Thromb Res"},{"key":"ref103","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1002\/lt.24134","article-title":"Increased risk of portal vein thrombosis in patients with cirrhosis due to nonalcoholic steatohepatitis","volume":"21","author":"Stine","year":"2015","journal-title":"Liver Transpl"},{"key":"ref104","first-page":"38","article-title":"Spontaneous bacterial peritonitis: a severe complication of liver cirrhosis","volume":"115","author":"Balan","year":"2011","journal-title":"Rev Med Chir Soc Med Nat Iasi"},{"key":"ref105","doi-asserted-by":"publisher","first-page":"56","DOI":"10.4166\/kjg.2018.72.2.56","article-title":"Spontaneous bacterial peritonitis","volume":"72","author":"Song","year":"2018","journal-title":"Korean J Gastroenterol"},{"key":"ref106","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/0168-8278(88)80018-7","article-title":"Translocated intestinal bacteria cause spontaneous bacterial peritonitis in cirrhotic rats: molecular epidemiologic evidence","volume":"28","author":"Llovet","year":"1998","journal-title":"J Hepatol"},{"key":"ref107","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1556\/oh.2007.27882","article-title":"Bacterial infections in cirrhosis","volume":"148","author":"Papp","year":"2007","journal-title":"Orv Hetil"},{"key":"ref108","doi-asserted-by":"publisher","first-page":"e3489","DOI":"10.1097\/MD.0000000000003489","article-title":"Predictive factors of spontaneous bacterial peritonitis caused by Gram-positive bacteria in patients with cirrhosis","volume":"95","author":"Kim","year":"2016","journal-title":"Medicine"},{"key":"ref109","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.cgh.2018.07.022","article-title":"Association between intestinal microbiota collected at hospital admission and outcomes of patients with cirrhosis","volume":"17","author":"Bajaj","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref110","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1002\/ncp.10181","article-title":"Proton pump inhibitors: risks and rewards and emerging consequences to the gut microbiome","volume":"33","author":"Singh","year":"2018","journal-title":"Nutr Clin Pract"},{"key":"ref111","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1136\/gutjnl-2020-320786","article-title":"Targeting the gut-liver-immune axis to treat cirrhosis","volume":"70","author":"Tranah","year":"2021","journal-title":"Gut"},{"key":"ref112","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1038\/cr.2008.289","article-title":"FXR: a metabolic regulator and cell protector","volume":"18","author":"Wang","year":"2008","journal-title":"Cell Res"},{"key":"ref113","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/j.jhep.2019.06.017","article-title":"FXR modulates the gut-vascular barrier by regulating the entry sites for bacterial translocation in experimental cirrhosis","volume":"71","author":"Sorribas","year":"2019","journal-title":"J Hepatol"},{"key":"ref114","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1097\/MCG.0b013e3182506dbb","article-title":"The role of rifaximin in the primary prophylaxis of spontaneous bacterial peritonitis in patients with liver cirrhosis","volume":"46","author":"Hanouneh","year":"2012","journal-title":"J Clin Gastroenterol"},{"key":"ref115","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1053\/j.gastro.2018.08.026","article-title":"Effects of long-term norfloxacin therapy in patients with advanced cirrhosis","volume":"155","author":"Moreau","year":"2018","journal-title":"Gastroenterology"},{"key":"ref116","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1097\/MEG.0000000000000724","article-title":"Randomized-controlled trial of rifaximin versus norfloxacin for secondary prophylaxis of spontaneous bacterial peritonitis","volume":"28","author":"Elfert","year":"2016","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref117","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s12325-013-0044-1","article-title":"Targeting the gut-liver axis in cirrhosis: antibiotics and non-selective \u03b2-blockers","volume":"30","author":"Madsen","year":"2013","journal-title":"Adv Ther"},{"key":"ref118","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.jhep.2012.12.011","article-title":"Non-selective betablocker therapy decreases intestinal permeability and serum levels of LBP and IL-6 in patients with cirrhosis","volume":"58","author":"Reiberger","year":"2013","journal-title":"J Hepatol"},{"key":"ref119","doi-asserted-by":"publisher","first-page":"26800","DOI":"10.1038\/srep26800","article-title":"Impaired gut-liver-brain axis in patients with cirrhosis","volume":"6","author":"Ahluwalia","year":"2016","journal-title":"Sci Rep"},{"key":"ref120","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1056\/NEJMra1600561","article-title":"Hepatic encephalopathy","volume":"375","author":"Wijdicks","year":"2016","journal-title":"N Engl J Med"},{"key":"ref121","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S0197-0186(02)00040-2","article-title":"Interorgan ammonia metabolism in liver failure","volume":"41","author":"Olde Damink","year":"2002","journal-title":"Neurochem Int"},{"key":"ref122","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/nrgastro.2013.99","article-title":"The liver-brain axis in liver failure: neuroinflammation and encephalopathy","volume":"10","author":"Butterworth","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref123","doi-asserted-by":"publisher","first-page":"G168","DOI":"10.1152\/ajpgi.00190.2011","article-title":"Linkage of gut microbiome with cognition in hepatic encephalopathy","volume":"302","author":"Bajaj","year":"2012","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"ref124","doi-asserted-by":"publisher","first-page":"8355","DOI":"10.3748\/wjg.v23.i47.8355","article-title":"Rifaximin ameliorates hepatic encephalopathy and endotoxemia without affecting the gut microbiome diversity","volume":"23","author":"Kaji","year":"2017","journal-title":"World J Gastroenterol"},{"key":"ref125","doi-asserted-by":"publisher","first-page":"133410","DOI":"10.1172\/jci.insight.133410","article-title":"Microbial functional change is linked with clinical outcomes after capsular fecal transplant in cirrhosis","volume":"4","author":"Bajaj","year":"2019","journal-title":"JCI Insight"},{"key":"ref126","doi-asserted-by":"publisher","first-page":"489","DOI":"10.4254\/wjh.v11.i6.489","article-title":"Dietary approach and gut microbiota modulation for chronic hepatic encephalopathy in cirrhosis","volume":"11","author":"Campion","year":"2019","journal-title":"World J Hepatol"},{"key":"ref127","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1002\/med.21653","article-title":"Expert insights: the potential role of the gut microbiome-bile acid-brain axis in the development and progression of Alzheimer\u2019s disease and hepatic encephalopathy","volume":"40","author":"Jia","year":"2020","journal-title":"Med Res Rev"},{"key":"ref128","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.bbr.2014.07.027","article-title":"Serotonin, tryptophan metabolism and the brain-gut-microbiome axis","volume":"277","author":"O\u2019Mahony","year":"2015","journal-title":"Behav Brain Res"},{"key":"ref129","doi-asserted-by":"publisher","first-page":"8210","DOI":"10.1038\/s41598-018-26509-y","article-title":"Combining amplicon sequencing and metabolomics in cirrhotic patients highlights distinctive microbiota features involved in bacterial translocation, systemic inflammation and hepatic encephalopathy","volume":"8","author":"Iebba","year":"2018","journal-title":"Sci Rep"},{"key":"ref130","doi-asserted-by":"publisher","first-page":"S121","DOI":"10.1016\/j.jhep.2015.01.003","article-title":"Evolution in the understanding of the pathophysiological basis of portal hypertension: how changes in paradigm are leading to successful new treatments","volume":"62","author":"Bosch","year":"2015","journal-title":"J Hepatol"},{"key":"ref131","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s12072-017-9798-x","article-title":"Gut-liver axis, cirrhosis and portal hypertension: the chicken and the egg","volume":"12","author":"Arab","year":"2018","journal-title":"Hepatol Int"},{"key":"ref132","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1159\/000490262","article-title":"Gut-liver axis links portal hypertension to acute-on-chronic liver failure","volume":"34","author":"Trebicka","year":"2018","journal-title":"Visc Med"},{"key":"ref133","doi-asserted-by":"publisher","first-page":"5897","DOI":"10.3748\/wjg.v25.i39.5897","article-title":"Gut-liver axis signaling in portal hypertension","volume":"25","author":"Simbrunner","year":"2019","journal-title":"World J Gastroenterol"},{"key":"ref134","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1038\/labinvest.2010.60","article-title":"Intraperitoneal LPS amplifies portal hypertension in rat liver fibrosis","volume":"90","author":"Steib","year":"2010","journal-title":"Lab Investig"},{"key":"ref135","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1002\/hep.28264","article-title":"Development of hyperdynamic circulation and response to \u03b2-blockers in compensated cirrhosis with portal hypertension","volume":"63","author":"Villanueva","year":"2016","journal-title":"Hepatology"},{"key":"ref136","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.jhep.2016.11.001","article-title":"Beta adrenergic blockade and decompensated cirrhosis","volume":"66","author":"Reiberger","year":"2017","journal-title":"J Hepatol"},{"key":"ref137","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.jhep.2016.12.005","article-title":"The FXR agonist PX20606 ameliorates portal hypertension by targeting vascular remodelling and sinusoidal dysfunction","volume":"66","author":"Schwabl","year":"2017","journal-title":"J Hepatol"},{"key":"ref138","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.jhep.2011.11.013","article-title":"Intestinal decontamination inhibits TLR4 dependent fibronectin-mediated cross-talk between stellate cells and endothelial cells in liver fibrosis in mice","volume":"56","author":"Zhu","year":"2012","journal-title":"J Hepatol"},{"key":"ref139","doi-asserted-by":"publisher","first-page":"774","DOI":"10.2215\/CJN.12451018","article-title":"Hepatorenal syndrome","volume":"14","author":"Francoz","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref140","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.semnephrol.2018.10.002","article-title":"Epidemiology, pathophysiology, and management of hepatorenal syndrome","volume":"39","author":"Amin","year":"2019","journal-title":"Semin Nephrol"},{"key":"ref141","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.cld.2019.06.002","article-title":"Ascites and hepatorenal syndrome","volume":"23","author":"Adebayo","year":"2019","journal-title":"Clin Liver Dis"},{"key":"ref142","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1097\/SHK.0b013e318244b787","article-title":"Endotoxemia exacerbates kidney injury and increases asymmetric dimethylarginine in young bile duct-ligated rats","volume":"37","author":"Huang","year":"2012","journal-title":"Shock"},{"key":"ref143","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1136\/jim-2019-001056","article-title":"Role of endotoxemia in causing renal dysfunction in cirrhosis","volume":"68","author":"Peng","year":"2020","journal-title":"J Investig Med"},{"key":"ref144","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/j.jhep.2011.11.024","article-title":"Prevention of acute kidney injury in a rodent model of cirrhosis following selective gut decontamination is associated with reduced renal TLR4 expression","volume":"56","author":"Shah","year":"2012","journal-title":"J Hepatol"},{"key":"ref145","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.cgh.2012.02.025","article-title":"Rifaximin improves systemic hemodynamics and renal function in patients with alcohol-related cirrhosis and ascites","volume":"10","author":"Kalambokis","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref146","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1111\/liv.12528","article-title":"Albumin infusion improves renal blood flow autoregulation in patients with acute decompensation of cirrhosis and acute kidney injury","volume":"35","author":"Garcia-Martinez","year":"2015","journal-title":"Liver Int"},{"key":"ref147","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jcrc.2016.04.019","article-title":"Fluid management in sepsis: the potential beneficial effects of albumin","volume":"35","author":"Vincent","year":"2016","journal-title":"J Crit Care"},{"key":"ref148","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1093\/ndt\/gfw014","article-title":"Altered circadian hemodynamic and renal function in cirrhosis","volume":"32","author":"Liangpunsakul","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"ref149","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.cld.2014.01.003","article-title":"Hepatopulmonary syndrome","volume":"18","author":"Koch","year":"2014","journal-title":"Clin Liver Dis"},{"key":"ref150","first-page":"355","article-title":"Progress in investigating the pathogenesis of hepatopulmonary syndrome","volume":"9","author":"Zhang","year":"2010","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"ref151","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/nrgastro.2012.123","article-title":"Hepatopulmonary syndrome: update on pathogenesis and clinical features","volume":"9","author":"Zhang","year":"2012","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref152","doi-asserted-by":"publisher","first-page":"2586","DOI":"10.3748\/wjg.v20.i10.2586","article-title":"Cirrhosis and hepatopulmonary syndrome","volume":"20","author":"Tumgor","year":"2014","journal-title":"World J Gastroenterol"},{"key":"ref153","doi-asserted-by":"publisher","first-page":"3500","DOI":"10.3748\/wjg.v13.i25.3500","article-title":"Multiple pathogenic factor-induced complications of cirrhosis in rats: a new model of hepatopulmonary syndrome with intestinal endotoxemia","volume":"13","author":"Zhang","year":"2007","journal-title":"World J Gastroenterol"},{"key":"ref154","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1111\/j.1440-1746.2005.03914.x","article-title":"Cirrhotic rats with bacterial translocation have higher incidence and severity of hepatopulmonary syndrome","volume":"20","author":"Sztrymf","year":"2005","journal-title":"J Gastroenterol Hepatol"},{"key":"ref155","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1016\/j.cgh.2010.08.011","article-title":"Norfloxacin therapy for hepatopulmonary syndrome: a pilot randomized controlled trial","volume":"8","author":"Gupta","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref156","doi-asserted-by":"publisher","first-page":"16018","DOI":"10.1038\/nrdp.2016.18","article-title":"Hepatocellular carcinoma","volume":"2","author":"Llovet","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"ref157","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1146\/annurev-med-090514-013832","article-title":"Liver cancer: connections with obesity, fatty liver, and cirrhosis","volume":"67","author":"Marengo","year":"2016","journal-title":"Annu Rev Med"},{"key":"ref158","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13099-018-0281-6","article-title":"Alteration in gut microbiota associated with hepatitis B and non-hepatitis virus related hepatocellular carcinoma","volume":"11","author":"Liu","year":"2019","journal-title":"Gut Pathog"},{"key":"ref159","doi-asserted-by":"publisher","first-page":"4814","DOI":"10.3748\/wjg.v25.i33.4814","article-title":"Intestinal permeability in the pathogenesis of liver damage: from non-alcoholic fatty liver disease to liver transplantation","volume":"25","author":"Nicoletti","year":"2019","journal-title":"World J Gastroenterol"},{"key":"ref160","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41418-019-0340-7","article-title":"Lipopolysaccharide induces the differentiation of hepatic progenitor cells into myofibroblasts constitutes the hepatocarcinogenesis-associated microenvironment","volume":"27","author":"Liu","year":"2020","journal-title":"Cell Death Differ"},{"key":"ref161","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1002\/hep.23845","article-title":"Endotoxin accumulation prevents carcinogen-induced apoptosis and promotes liver tumorigenesis in rodents","volume":"52","author":"Yu","year":"2010","journal-title":"Hepatology"},{"key":"ref162","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1002\/hep.30036","article-title":"Hepatocellular carcinoma is associated with gut microbiota profile and inflammation in nonalcoholic fatty liver disease","volume":"69","author":"Ponziani","year":"2019","journal-title":"Hepatology"},{"key":"ref163","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.aohep.2018.10.003","article-title":"A different gut microbiome linked to inflammation found in cirrhotic patients with and without hepatocellular carcinoma","volume":"18","author":"Pi\u00f1ero","year":"2019","journal-title":"Ann Hepatol"},{"key":"ref164","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/s41586-019-1742-x","article-title":"Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease","volume":"575","author":"Duan","year":"2019","journal-title":"Nature"},{"key":"ref165","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.coph.2017.10.010","article-title":"MicroRNAs in intestinal barrier function, inflammatory bowel disease and related cancers-their effects and therapeutic potentials","volume":"37","author":"Tili","year":"2017","journal-title":"Curr Opin Pharmacol"},{"key":"ref166","doi-asserted-by":"publisher","first-page":"S240","DOI":"10.1016\/S0168-8278(15)30110-0","article-title":"Oral therapy with non-absorbable carbons of controlled porosity (YAQ-001) selectively modulates stool microbiome and its function and this is associated with restoration of immune function and inflammasome activation","volume":"62","author":"Macnaughtan","year":"2015","journal-title":"J Hepatol"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1320015\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T04:15:59Z","timestamp":1705378559000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1320015\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,16]]},"references-count":166,"alternative-id":["10.3389\/fmed.2023.1320015"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2023.1320015","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,16]]},"article-number":"1320015"}}